JP2015528562A5 - - Google Patents

Download PDF

Info

Publication number
JP2015528562A5
JP2015528562A5 JP2015525897A JP2015525897A JP2015528562A5 JP 2015528562 A5 JP2015528562 A5 JP 2015528562A5 JP 2015525897 A JP2015525897 A JP 2015525897A JP 2015525897 A JP2015525897 A JP 2015525897A JP 2015528562 A5 JP2015528562 A5 JP 2015528562A5
Authority
JP
Japan
Prior art keywords
igfbp2
concentration
heart failure
patient
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015525897A
Other languages
English (en)
Japanese (ja)
Other versions
JP6298054B2 (ja
JP2015528562A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/066697 external-priority patent/WO2014023820A1/en
Publication of JP2015528562A publication Critical patent/JP2015528562A/ja
Publication of JP2015528562A5 publication Critical patent/JP2015528562A5/ja
Application granted granted Critical
Publication of JP6298054B2 publication Critical patent/JP6298054B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015525897A 2012-08-09 2013-08-09 心不全の診断 Expired - Fee Related JP6298054B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12305988.3 2012-08-09
EP12305988 2012-08-09
PCT/EP2013/066697 WO2014023820A1 (en) 2012-08-09 2013-08-09 Diagnostic of heart failure

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018029702A Division JP6595641B2 (ja) 2012-08-09 2018-02-22 心不全の診断

Publications (3)

Publication Number Publication Date
JP2015528562A JP2015528562A (ja) 2015-09-28
JP2015528562A5 true JP2015528562A5 (https=) 2016-09-15
JP6298054B2 JP6298054B2 (ja) 2018-03-20

Family

ID=48953397

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015525897A Expired - Fee Related JP6298054B2 (ja) 2012-08-09 2013-08-09 心不全の診断
JP2018029702A Active JP6595641B2 (ja) 2012-08-09 2018-02-22 心不全の診断

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018029702A Active JP6595641B2 (ja) 2012-08-09 2018-02-22 心不全の診断

Country Status (16)

Country Link
US (2) US20150219669A1 (https=)
EP (1) EP2883057B1 (https=)
JP (2) JP6298054B2 (https=)
CY (1) CY1121406T1 (https=)
DK (1) DK2883057T3 (https=)
ES (1) ES2713098T3 (https=)
HR (1) HRP20190341T1 (https=)
HU (1) HUE042708T2 (https=)
LT (1) LT2883057T (https=)
PL (1) PL2883057T3 (https=)
PT (1) PT2883057T (https=)
RS (1) RS58553B1 (https=)
SI (1) SI2883057T1 (https=)
SM (1) SMT201900108T1 (https=)
TR (1) TR201902555T4 (https=)
WO (1) WO2014023820A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11112414B2 (en) 2013-06-06 2021-09-07 Inserm (Institute National De Las Sante Et De La Recherche Medicale) Biomarker of rehospitalization after heart failure
JP7401442B2 (ja) * 2018-01-31 2023-12-19 イントラ-セルラー・セラピーズ・インコーポレイテッド 新規使用
JP7510649B2 (ja) * 2019-11-06 2024-07-04 国立大学法人 香川大学 心不全マーカー
CN120053474B (zh) * 2025-02-26 2025-12-12 浙江大学 辅酶a在制备心肌细胞铁死亡抑制剂中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060183681A1 (en) * 2005-02-14 2006-08-17 Bio-Rad Laboratories, Inc. Stabilized compositions containing natriuretic peptides
JP4465469B2 (ja) * 2005-02-21 2010-05-19 国立大学法人佐賀大学 循環器病マーカーとしてのインターロイキン13
EP1722232A1 (en) 2005-05-09 2006-11-15 F.Hoffmann-La Roche Ag Devices and methods for diagnosing or predicting early stage cardiac dysfunctions
US20080166734A1 (en) * 2005-12-21 2008-07-10 David Xing-Fei Deng Genes and methods of using the same for diagnosis and for targeting the therapy of cardiovascular disease
US20080112888A1 (en) 2006-06-30 2008-05-15 Schering Corporation Igfbp2 biomarker
JP2010517023A (ja) 2007-01-25 2010-05-20 エフ.ホフマン−ラ ロシュ アーゲー 心不全の評価におけるigfbp−7の使用
EP2310860A1 (en) * 2008-07-30 2011-04-20 INSERM - Institut National de la Santé et de la Recherche Médicale Blood glutathione as a biomarker for screening asymptomatic patients at risk for heart failure
PT2829881T (pt) * 2010-07-14 2017-11-29 Commw Scient Ind Res Org Diagnóstico para cancro colo-rectal
CN105044349B (zh) * 2010-08-26 2018-04-06 弗·哈夫曼-拉罗切有限公司 生物标志物在评估从动脉高血压向心力衰竭的早期转变中的用途
EP2841945A4 (en) 2012-04-24 2016-04-27 Astute Medical Inc METHOD AND COMPOSITIONS FOR DIAGNOSIS AND FORECASTING OF STROKE OR OTHER BRAINS
US20140206632A1 (en) * 2013-01-22 2014-07-24 Singulex, Inc. Endothelin in the Diagnosis of Cardiac Disease

Similar Documents

Publication Publication Date Title
JP2016520192A5 (https=)
JP2013533977A5 (https=)
JP2016500110A5 (https=)
JP2015505370A5 (https=)
JP2015528562A5 (https=)
MX2020009705A (es) Metodos para la deteccion del riesgo de enfermedad renal cronica en un sujeto y metodo implementado por computadora.
RU2013138721A (ru) Способы и наборы для прогнозирования риска дыхательной недостаточности, почечной недостаточности или тромбопении у пациента, страдающего сепсисом, путем измерения уровней эндокана в крови
JP2018511055A5 (https=)
JP2018004657A5 (https=)
CY1119797T1 (el) Λακτοφερινη για χρηση στη διαγνωση και προγνωση της νοσου alzheimer
WO2016166031A1 (en) Serum biomarker for hepatocellular carcinoma (hcc)
JP2016526167A5 (https=)
JP2014517308A5 (https=)
JP2015505371A5 (https=)
JP2011528797A5 (https=)
HRP20190341T1 (hr) Dijagnosticiranje srčane insuficijencije
JP2017524933A5 (https=)
HRP20191862T1 (hr) Procjena rizika u liječenju antibioticima kod pacijenata koji boluju od primarne nezarazne bolesti određivanjem razine prokalcitonina
HRP20190801T1 (hr) Biološki biljeg za rehospitalizaciju nakon srčane insuficijencije
NZ601643A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
JP6727660B2 (ja) 糖尿病性腎症の判定マーカー
JP2017526924A5 (https=)
JP2018536152A5 (https=)
RU2017109086A (ru) Прогностический маркер hf
Islam et al. Comparative analyses of adsorbed circulating proteins in the PMMA and PES hemodiafilters in patients on predilution online hemodiafiltration